Evidence map›Paper›PMID 25279014›Full record

ArticleJournal of neurodevelopmental disorders2014

Pre-pulse inhibition and antisaccade performance indicate impaired attention modulation of cognitive inhibition in 22q11.2 deletion syndrome (22q11DS).

Kathryn Louise McCabe, Rebbekah Josephine Atkinson, Gavin Cooper, Jessica Lauren Melville, Jill Harris, Ulrich Schall, Carmel Maree Loughland, Renate Thienel, Linda Elisabet Campbell

Open access · goldAbstract read
In one paragraph

Article in Journal of neurodevelopmental disorders, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Kathryn Louise McCabeSchizophrenia Research Institute, Darlinghurst, Australia ; Brain & Mind Research Institute, University of Sydney, Sydney, Australia ; Centre for Translational Neuroscience & Mental Health, University of Newcastle, Callaghan, Newcastle Australia.
Rebbekah Josephine AtkinsonSchizophrenia Research Institute, Darlinghurst, Australia ; Centre for Translational Neuroscience & Mental Health, University of Newcastle, Callaghan, Newcastle Australia ; School of Medicine & Public Health, University of Newcastle, Callaghan, Newcastle, Australia.
Gavin CooperSchizophrenia Research Institute, Darlinghurst, Australia ; Centre for Translational Neuroscience & Mental Health, University of Newcastle, Callaghan, Newcastle Australia ; School of Psychology, University of Newcastle, Science Offices, Callaghan, Ourimbah, NSW 2258 Australia.
Jessica Lauren MelvilleCentre for Translational Neuroscience & Mental Health, University of Newcastle, Callaghan, Newcastle Australia ; School of Psychology, University of Newcastle, Science Offices, Callaghan, Ourimbah, NSW 2258 Australia.
Jill HarrisMinerals Industry Safety and Health Centre, University of Queensland, Brisbane, Australia.
Ulrich SchallSchizophrenia Research Institute, Darlinghurst, Australia ; Centre for Translational Neuroscience & Mental Health, University of Newcastle, Callaghan, Newcastle Australia ; School of Medicine & Public Health, University of Newcastle, Callaghan, Newcastle, Australia.
Carmel Maree LoughlandSchizophrenia Research Institute, Darlinghurst, Australia ; Centre for Translational Neuroscience & Mental Health, University of Newcastle, Callaghan, Newcastle Australia.
Renate ThienelSchizophrenia Research Institute, Darlinghurst, Australia ; Centre for Translational Neuroscience & Mental Health, University of Newcastle, Callaghan, Newcastle Australia ; School of Medicine & Public Health, University of Newcastle, Callaghan, Newcastle, Australia.
Linda Elisabet CampbellSchizophrenia Research Institute, Darlinghurst, Australia ; Centre for Translational Neuroscience & Mental Health, University of Newcastle, Callaghan, Newcastle Australia ; School of Psychology, University of Newcastle, Science Offices, Callaghan, Ourimbah, NSW 2258 Australia.
Schizophrenia Research Institute · AUUniversity of Newcastle Australia · AUUniversity of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background22q11.2 deletion syndrome (22q11DS) is associated with a number of physical anomalies and neuropsychological deficits including impairments in executive and sensorimotor function. It is estimated that 25% of children with 22q11DS will develop schizophrenia and other psychotic disorders later in life. Evidence of genetic transmission of information processing deficits in schizophrenia suggests performance in 22q11DS individuals will enhance understanding of the neurobiological and genetic substrates associated with information processing. In this report, we examine information processing in 22q11DS using measures of startle eyeblink modification and antisaccade inhibition to explore similarities with schizophrenia and associations with neurocognitive performance.

methodsStartle modification (passive and active tasks; 120- and 480-ms pre-pulse intervals) and antisaccade inhibition were measured in 25 individuals with genetically confirmed 22q11DS and 30 healthy control subjects.

resultsIndividuals with 22q11DS exhibited increased antisaccade error as well as some evidence (trend-level effect) of impaired sensorimotor gating during the active condition, suggesting a dysfunction in controlled attentional processing, rather than a pre-attentive dysfunction using this paradigm.

conclusionsThe findings from the present study show similarities with previous studies in clinical populations associated with 22q11DS such as schizophrenia that may indicate shared dysfunction of inhibition pathways in these groups.

Indexed as

AntisaccadeNeurocognitionPPFPPIStartle modification

Identifiers

PMID25279014
PMCPMC4182838
OpenAlexW2160972519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.